MARKET

XTNT

XTNT

XTANT MEDICAL
AMEX

Real-time Quotes | Nasdaq Last Sale

0.9499
+0.0100
+1.06%
Closed 16:00 07/10 EDT
OPEN
0.9400
PREV CLOSE
0.9399
HIGH
0.9500
LOW
0.9300
VOLUME
40.38K
TURNOVER
--
52 WEEK HIGH
3.500
52 WEEK LOW
0.5500
MARKET CAP
12.56M
P/E (TTM)
-1.5799
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average XTNT stock price target is 2.000 with a high estimate of 2.000 and a low estimate of 2.000.

EPS

XTNT News

More
Edited Transcript of XTNT earnings conference call or presentation 7-May-20 1:00pm GMT
Thomson Reuters StreetEvents · 06/12 05:28
Hedge Funds Watching Xtant Medical Holdings, Inc. (XTNT) From Afar
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings
Insider Monkey · 05/29 18:24
28 Stocks Moving in Tuesday's Pre-Market Session
Gainers Mmtec, Inc. (NASDAQ: MTC) shares rose 77.2% to $1.95 in pre-market trading after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797,in 2019.
Benzinga · 05/26 11:18
71 Biggest Movers From Friday
Gainers Inari Medical, Inc. (NASDAQ: NARI) shares surged 123.7% to close at $42.51 on Friday after pricing its IPO on Friday.
Benzinga · 05/26 08:30
46 Stocks Moving In Friday's Mid-Day Session
Gainers Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) shares jumped 98.40% to $2.5201 after the company announced positive preliminary results from the second interim analysis of its ongoing NAV3-31 Phase 2B study.
Benzinga · 05/22 16:45
FL, HPE among premarket losers
Seeking Alpha - Article · 05/22 13:19
30 Stocks Moving in Friday's Pre-Market Session
Gainers Navidea Biopharmaceuticals, Inc. (NASDAQ: NAVB) shares rose 65.2% to $2.18 in pre-market trading after the company reported results of second interim analysis of ongoing Phase 2B study in rheumatoid arthritis.
Benzinga · 05/22 11:18
Xtant Medical up big on OrbiMed stake
Thinly traded nano cap Xtant Medical Holdings (NYSEMKT:XTNT) rockets 223% premarket on robust volume in apparent response to a regulatory filing by OrbiMed
seekingalpha · 05/21 17:23

Industry

Medical Equipment, Supplies & Distribution
-0.13%
Healthcare Equipment & Supplies
-0.35%

Hot Stocks

Symbol
Price
%Change

About XTNT

Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.
More

Webull offers kinds of Xtant Medical Holdings Inc stock information, including AMEX:XTNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XTNT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading XTNT stock methods without spending real money on the virtual paper trading platform.